GBM samples (n=13) showed a 3.9 fold increase in SGK1 mRNA expression compared to control samples (n=5) (P=0.01), whereas meningioma samples (n=2) were characterized by a level of SGK1 mRNA expression comparable with the one of normal brain tissue (Figure 1). Here, SGK1 is linked to meningioma.